Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





Horiba Showcases HELO Global Hematology Solution at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023

Horiba Medical (Kyoto, Japan) is showcasing its extensive and comprehensive line of hematology, hemostasis, and clinical chemistry solutions, including analyzers, reagents, and consumables, for in vitro diagnostics at Medlab Middle East 2023.

At this year’s Medlab Middle East, Horiba is presenting HELO (HORIBA Evolutive Laboratory Organization), its global hematology solution. With an innovative design solution covering all the needs of a high throughput automated hematology platform, the flexible and efficient HELO is the optimum answer to the constant evolution of laboratories. The HORIBA advanced technologies embedded in the Yumizen H2500/H1500 associated with over 30 years of experience in hematology diagnosis offer the highest analytical performances. Thanks to its data, tube management, blood film, and digitalization management capability, HELO not only addresses all needs but also helps optimize TAT, floor space and reagent storage. HELO comes with Horiba’s accreditation assistance program which has been developed in accordance with ISO-15189 certification.

Horiba is also showcasing the new Yumizen H500 and H550 compact benchtop hematology analyzers with enhanced performance, new features, and increased benefits, alongside the Microsemi CRP LC-767G hematology analyzer that enables simultaneous blood analysis + CRP measurement, along with data management. In addition, Horiba is highlighting the Yumizen G1550/G1500 automated hemostasis analyzer that offers routine and specialized testing in a single analysis system, alongside the Yumizen G400 semi-automated hemostasis analyzer that offers a smart way to test with four independent measuring channels and 20 incubation positions.

Among its clinical chemistry solutions, Horiba is presenting the Pentra C200 clinical chemistry analyzer with fixed cycles that provides a continuous throughput of 90 colorimetric tests/hour, alongside the Pentra C400 clinical chemistry analyzer that features 55 on-board assays, an innovative cassette format, and integrated workstation and validation station. Among its laboratory automation solutions, Horiba is showcasing the Yumizen T6000 automated rack conveyor that is fully compatible with laboratory architecture (spaces, walls, columns) due to wide configurations of panels (linear, work cell, angular, island), alongside the Cube S robotic workstation that manages pre and post-analytical sorting, storing, and tracking of sample tubes in a laboratory.

Related Links:
Horiba Medical

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.